Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.

Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L.

Adv Ther. 2019 Feb;36(2):462-477. doi: 10.1007/s12325-018-0855-1. Epub 2018 Dec 14.

PMID:
30552587
2.

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.

Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E.

Oncogene. 2019 Feb;38(7):950-964. doi: 10.1038/s41388-018-0579-3. Epub 2018 Nov 26.

PMID:
30478447
3.

The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis.

Gineyts E, Bonnet N, Bertholon C, Millet M, Pagnon-Minot A, Borel O, Geraci S, Bonnelye E, Croset M, Suhail A, Truica C, Lamparella N, Leitzel K, Hartmann D, Chapurlat R, Lipton A, Garnero P, Ferrari S, Clézardin P, Rousseau JC.

Calcif Tissue Int. 2018 Nov;103(5):567-580. doi: 10.1007/s00223-018-0444-y. Epub 2018 Jun 18.

PMID:
29916127
4.

Efficacy and safety of Velmanase alfa in the treatment of patients with alpha-mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double-blind, randomised, placebo-controlled trial.

Borgwardt L, Guffon N, Amraoui Y, Dali CI, De Meirleir L, Gil-Campos M, Heron B, Geraci S, Ardigò D, Cattaneo F, Fogh J, Van den Hout JMH, Beck M, Jones SA, Tylki-Szymanska A, Haugsted U, Lund AM.

J Inherit Metab Dis. 2018 Nov;41(6):1215-1223. doi: 10.1007/s10545-018-0185-0. Epub 2018 May 30.

5.

Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis.

Lund AM, Borgwardt L, Cattaneo F, Ardigò D, Geraci S, Gil-Campos M, De Meirleir L, Laroche C, Dolhem P, Cole D, Tylki-Szymanska A, Lopez-Rodriguez M, Guillén-Navarro E, Dali CI, Héron B, Fogh J, Muschol N, Phillips D, Van den Hout JMH, Jones SA, Amraoui Y, Harmatz P, Guffon N.

J Inherit Metab Dis. 2018 Nov;41(6):1225-1233. doi: 10.1007/s10545-018-0175-2. Epub 2018 May 3.

6.

Enzyme replacement therapy with velmanase alfa (human recombinant alpha-mannosidase): Novel global treatment response model and outcomes in patients with alpha-mannosidosis.

Harmatz P, Cattaneo F, Ardigò D, Geraci S, Hennermann JB, Guffon N, Lund A, Hendriksz CJ, Borgwardt L.

Mol Genet Metab. 2018 Jun;124(2):152-160. doi: 10.1016/j.ymgme.2018.04.003. Epub 2018 Apr 18.

7.

A Case of a Reversible Neurologic Adverse Reaction to Apixaban Confirmed by Re-Challenge.

Josyln JA, Khattak FH, Geraci SA.

J Clin Med Res. 2018 Jun;10(6):523-526. doi: 10.14740/jocmr3394w. Epub 2018 Apr 13.

8.

[For an epidemiology of migration in Italy: the opportunity of new partnerships].

Marceca M, Baglio G, Geraci S.

Epidemiol Prev. 2018 Jan-Feb;42(1):7-8. doi: 10.19191/EP18.1.P007.006. Italian. No abstract available.

PMID:
29506352
9.

Coronary Artery Fistulae: Anatomy, Diagnosis and Management Strategies.

Buccheri D, Chirco PR, Geraci S, Caramanno G, Cortese B.

Heart Lung Circ. 2018 Aug;27(8):940-951. doi: 10.1016/j.hlc.2017.07.014. Epub 2018 Feb 9. Review.

PMID:
29503240
10.

Culture Shift: Building an Awareness of Our Mortality.

Macmillan P, Geraci SA.

Cureus. 2017 Dec 20;9(12):e1969. doi: 10.7759/cureus.1969.

11.

Will Cardio-Virology Be the Next Cardio-Oncology?

Geraci SA.

Am J Med. 2018 Jul;131(7):726-727. doi: 10.1016/j.amjmed.2018.01.023. Epub 2018 Feb 6. No abstract available.

PMID:
29425708
12.

A lesson from intravascular imaging: insights for recognizing a spontaneous coronary artery dissection.

Buccheri D, Milazzo D, Geraci S, Vaccaro G, Caramanno G.

J Thorac Dis. 2017 Dec;9(12):5363-5367. doi: 10.21037/jtd.2017.10.146. Review.

13.

Effect of intra-tibial injection on mechanical properties of mouse bone.

Delpuech B, Confavreux C, Bouazza L, Geraci S, Clezardin P, Mitton D, Follet H.

Comput Methods Biomech Biomed Engin. 2017 Oct;20(sup1):57-58. doi: 10.1080/10255842.2017.1382859. No abstract available.

PMID:
29088647
14.

Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.

Capranzano P, Capodanno D, Brugaletta S, Latib A, Mehilli J, Nef H, Gori T, Lesiak M, Geraci S, Pyxaras S, Mattesini A, Münzel T, Araszkiewicz A, Caramanno G, Naber C, Di Mario C, Sabatè M, Colombo A, Wiebe J, Tamburino C.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):444-453. doi: 10.1002/ccd.27388. Epub 2017 Oct 25.

PMID:
29068130
15.

C-Reactive Protein as an Independent Cardiovascular Risk Predictor in HIV+ Patients: A Focused Review of Published Studies.

Gilotra TS, Geraci SA.

J Clin Med Res. 2017 Nov;9(11):891-899. doi: 10.14740/jocmr3154w. Epub 2017 Oct 2. Review.

16.

A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study.

Ielasi A, Campo G, Rapetto C, Varricchio A, Cortese B, Brugaletta S, Geraci S, Vicinelli P, Scotto di Uccio F, Secco GG, Poli A, Nicolini E, Ishida K, Latib A, Tespili M.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1855-1864. doi: 10.1016/j.jcin.2017.07.023.

17.

Overexpression of a functional calcium-sensing receptor dramatically increases osteolytic potential of MDA-MB-231 cells in a mouse model of bone metastasis through epiregulin-mediated osteoprotegerin downregulation.

Boudot C, Hénaut L, Thiem U, Geraci S, Galante M, Saldanha P, Saidak Z, Six I, Clézardin P, Kamel S, Mentaverri R.

Oncotarget. 2017 Apr 10;8(34):56460-56472. doi: 10.18632/oncotarget.16999. eCollection 2017 Aug 22.

18.

Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: systematic review and meta-analysis of randomized clinical trials.

Pavasini R, Serenelli M, Gallo F, Bugani G, Geraci S, Vicinelli P, Campo G.

J Thorac Dis. 2017 Aug;9(Suppl 9):S887-S897. doi: 10.21037/jtd.2017.06.59.

19.

Reply: Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU (Gauging coronary Healing with bioresorbable Scaffolding plaTforms in EUrope) Registry.

Geraci S, Kawamoto H, Capodanno D, Caramanno G, Latib A.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1275-1276. doi: 10.1016/j.jcin.2017.05.013. No abstract available.

20.

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS).

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli AL, Petronio AS, Bedogni F.

EuroIntervention. 2017 Jul 20;13(4):424-431. doi: 10.4244/EIJ-D-17-00246.

21.

Combining new tools to assess renal function and morphology: a holistic approach to study the effects of aging and a congenital nephron deficit.

Geraci S, Chacon-Caldera J, Cullen-McEwen L, Schad LR, Sticht C, Puelles VG, Bertram JF, Gretz N.

Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F576-F584. doi: 10.1152/ajprenal.00329.2015. Epub 2017 May 10.

22.

Should we reconsider dual antiplatelet therapy duration following bioresorbable scaffold angioplasty?

Buccheri D, Caramanno G, Geraci S, Cortese B.

J Thorac Dis. 2017 Mar;9(3):417-418. doi: 10.21037/jtd.2017.03.05. No abstract available.

23.

Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions.

Jabbour RJ, Tanaka A, Capranzano P, Cortese B, Lesiak M, Testa L, Gatto P, Suarez de Lezo J, Mattesini A, Geraci S, Ielasi A, Diletti R, Capodanno D, Buccheri D, Iwanczyk S, Bedogni F, Tchetche D, Di Mario C, Caramanno G, Van Mieghem NM, Tamburino C, Colombo A, Latib A.

JACC Cardiovasc Interv. 2017 Apr 10;10(7):743-745. doi: 10.1016/j.jcin.2017.01.038. No abstract available.

24.

Assessment of acute kidney injury in rhabdomyolytic mice by transcutaneous measurement of sinistrin excretion.

Moggio A, Geraci S, Boido A, Sticht C, Gretz N, Bussolati B.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1167-1175. doi: 10.1093/ndt/gfw438.

PMID:
28340139
25.

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabate M, Tamburino C, Nef H, Gori T.

EuroIntervention. 2017 Oct 13;13(9):e1104-e1111. doi: 10.4244/EIJ-D-16-00568.

26.

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

Geraci S, Kawamoto H, Caramanno G, Ruparelia N, Capodanno D, Brugaletta S, Gori T, Nef H, Sabate M, Mehilli J, Lesiak M, Naber C, Di Mario C, Capranzano P, Wiebe J, Araszkiewicz A, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Colombo A, Latib A.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):560-568. doi: 10.1016/j.jcin.2016.12.013. Epub 2017 Mar 1.

27.

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

EuroIntervention. 2017 Apr 20;12(17):2110-2117. doi: 10.4244/EIJ-D-16-00974.

PMID:
28246060
28.

Introduction.

Geraci SA.

Am J Med Sci. 2017 Feb;353(2):95. doi: 10.1016/j.amjms.2016.12.020. No abstract available.

PMID:
28183426
29.

A Review of Mentoring in Academic Medicine.

Geraci SA, Thigpen SC.

Am J Med Sci. 2017 Feb;353(2):151-157. doi: 10.1016/j.amjms.2016.12.002. Epub 2016 Dec 5.

PMID:
28183416
30.

Tenure and the Faculty Physician.

Geraci SA, Thigpen SC.

Am J Med Sci. 2017 Feb;353(2):145-150. doi: 10.1016/j.amjms.2016.12.008. Epub 2016 Dec 10.

PMID:
28183415
31.

Manuscript Development and Publishing: A 5-Step Approach.

Downey SM, Geraci SA.

Am J Med Sci. 2017 Feb;353(2):132-136. doi: 10.1016/j.amjms.2016.12.005. Epub 2016 Dec 9.

PMID:
28183413
32.

Healthcare utilization among urban homeless followed by an outpatient clinic: more intensive use by migrant groups.

Silvestrini G, Federico B, Damiani G, Geraci S, Bruno S, Maisano B, Ricciardi W, Kunst AE.

Eur J Public Health. 2017 Feb 1;27(1):96-101. doi: 10.1093/eurpub/ckw108. No abstract available.

PMID:
28177446
33.

Preventing Hospitalizations From Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Burchette JE, Campbell GD, Geraci SA.

Am J Med Sci. 2017 Jan;353(1):31-40. doi: 10.1016/j.amjms.2016.06.006. Epub 2016 Jul 2. Review.

PMID:
28104101
34.

Preventive and Primary Care for Lesbian, Gay and Bisexual Patients.

Floyd SR, Pierce DM, Geraci SA.

Am J Med Sci. 2016 Dec;352(6):637-643. doi: 10.1016/j.amjms.2016.05.008. Epub 2016 May 17. Review.

PMID:
27916220
35.

Cancer Screening 2016.

Thigpen SC, Geraci SA.

Am J Med Sci. 2016 Nov;352(5):493-501. doi: 10.1016/j.amjms.2016.06.001. Epub 2016 Jun 11. Review.

PMID:
27865297
36.

Maternal glucose intolerance reduces offspring nephron endowment and increases glomerular volume in adult offspring.

Hokke S, Arias N, Armitage JA, Puelles VG, Fong K, Geraci S, Gretz N, Bertram JF, Cullen-McEwen LA.

Diabetes Metab Res Rev. 2016 Nov;32(8):816-826. doi: 10.1002/dmrr.2805. Epub 2016 May 3.

PMID:
27037899
37.

Primary Aldosteronism: Diagnosis and Management.

Gyamlani G, Headley CM, Naseer A, Valaulikar GS, Geraci SA.

Am J Med Sci. 2016 Oct;352(4):391-398. doi: 10.1016/j.amjms.2016.06.015. Epub 2016 Jul 1. Review.

PMID:
27776721
38.

[SICI-GISE Position paper: Use of Absorb BVS in clinical practice].

Tarantini G, Saia F, Capranzano P, Cortese B, Mojoli M, Boccuzzi G, Cuculo A, Geraci S, Mattesini A, Oreglia J, Summaria F, Testa L, Berti S, Esposito G, La Manna A, Limbruno U, Marchese A, Mauro C, Tarantino F, Salvi A, Santoro G, Varbella F, Violini R, Musumeci G.

G Ital Cardiol (Rome). 2016 Oct;17(10 Suppl 1):28S-44. doi: 10.1714/2372.25480. Italian.

PMID:
27729667
39.

Allergy Medications During Pregnancy.

Gonzalez-Estrada A, Geraci SA.

Am J Med Sci. 2016 Sep;352(3):326-31. doi: 10.1016/j.amjms.2016.05.030. Epub 2016 Jun 3. Review.

PMID:
27650241
40.

Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.

Ortega-Paz L, Capodanno D, Giacchi G, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

Catheter Cardiovasc Interv. 2017 Apr;89(5):812-818. doi: 10.1002/ccd.26674. Epub 2016 Aug 12.

PMID:
27515568
41.

Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.

Naganuma T, Colombo A, Lesiak M, Capodanno D, Gori T, Nef H, Caramanno G, Naber C, Di Mario C, Ruparelia N, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Kawamoto H, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Latib A.

Catheter Cardiovasc Interv. 2017 Jan;89(1):47-56. doi: 10.1002/ccd.26634. Epub 2016 Jul 14.

PMID:
27414021
42.

Cardiovascular Toxicity and Management of Targeted Cancer Therapy.

Bossaer JB, Geraci SA, Chakraborty K.

Am J Med Sci. 2016 May;351(5):535-43. doi: 10.1016/j.amjms.2016.02.023. Epub 2016 Feb 17. Review.

PMID:
27140715
43.

Hybrid strategy with a bioresorbable scaffold and a drug-coated balloon for diffuse coronary artery disease: the "no more metallic cages" multicentre pilot experience.

Ielasi A, Miyazaki T, Geraci S, Testa L, Abdel-Wahab M, Kawamoto H, Ruparelia N, Sato T, Caramanno G, Bedogni F, Tespili M, Colombo A, Latib A.

EuroIntervention. 2016 Apr 8;11(14):e1589-95. doi: 10.4244/EIJV11I14A309.

44.

1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: A Propensity-Matched Comparison of the GHOST-EU and XIENCE V USA Registries.

Tamburino C, Capranzano P, Gori T, Latib A, Lesiak M, Nef H, Caramanno G, Naber C, Mehilli J, Di Mario C, Sabaté M, Münzel T, Colombo A, Araszkiewicz A, Wiebe J, Geraci S, Jensen C, Mattesini A, Brugaletta S, Capodanno D.

JACC Cardiovasc Interv. 2016 Mar 14;9(5):440-9. doi: 10.1016/j.jcin.2015.10.042. Epub 2016 Jan 6.

45.

Fast glomerular quantification of whole ex vivo mouse kidneys using Magnetic Resonance Imaging at 9.4 Tesla.

Chacon-Caldera J, Geraci S, Krämer P, Cullen-McEwen L, Bertram JF, Gretz N, Schad LR.

Z Med Phys. 2016 Mar;26(1):54-62. doi: 10.1016/j.zemedi.2015.12.008. Epub 2016 Jan 7.

PMID:
26777317
46.

Health transition and immigration: a new challenge for Public Health.

Di Nicola A, Geraci S.

Ann Ig. 2015 Sep-Oct;27(5):726-36. doi: 10.7416/ai.2015.2065.

PMID:
26661914
47.

Unseeded Inertial Cavitation for Enhancing the Delivery of Chemotherapies: A Safety Study.

Lafond M, Mestas JL, Prieur F, Chettab K, Geraci S, Clézardin P, Lafon C.

Ultrasound Med Biol. 2016 Jan;42(1):220-31. doi: 10.1016/j.ultrasmedbio.2015.08.019. Epub 2015 Oct 23.

PMID:
26478278
48.

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry.

Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras SA, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabate M, Mattesini A, Geraci S, Naber CK, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T.

EuroIntervention. 2016 Aug 5;12(5):e550-6. doi: 10.4244/EIJY15M09_10.

49.

Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.

Boccard SG, Marand SV, Geraci S, Pycroft L, Berger FR, Pelletier LA.

Oncotarget. 2015 Oct 6;6(30):29456-68. doi: 10.18632/oncotarget.4909.

50.

Measures of kidney function by minimally invasive techniques correlate with histological glomerular damage in SCID mice with adriamycin-induced nephropathy.

Scarfe L, Rak-Raszewska A, Geraci S, Darssan D, Sharkey J, Huang J, Burton NC, Mason D, Ranjzad P, Kenny S, Gretz N, Lévy R, Kevin Park B, García-Fiñana M, Woolf AS, Murray P, Wilm B.

Sci Rep. 2015 Sep 2;5:13601. doi: 10.1038/srep13601.

Supplemental Content

Loading ...
Support Center